Company Update Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Glenmark Strengthens Oncology Portfolio with Hengrui''s HER2 Targeting ADC for Multiple Regions